Wulff, Hansen & Co’s Pfizer PFE Stock Holding History

Wulff, Hansen & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$276K	Hold	11,475	–	–	0.21%	94
2026 Q1	$322K	Hold	11,475	–	–	0.33%	80
2025 Q4	$286K	Hold	11,475	–	–	0.24%	88
2025 Q3	$292K	Sell	11,475 -805	-7%	-$19.9K	0.25%	88
2025 Q2	$298K	Buy	12,280 +2,161	+21%	+$50.4K	0.25%	90
2025 Q1	$256K	Buy	10,119 +805	+9%	+$21.1K	0.23%	92
2024 Q4	$247K	Sell	9,314 -900	-9%	-$24.4K	0.23%	87
2024 Q3	$296K	Buy	10,214 +600	+6%	+$17.5K	0.27%	81
2024 Q2	$269K	Hold	9,614	–	–	0.27%	81
2024 Q1	$267K	Hold	9,614	–	–	0.27%	75
2023 Q4	$277K	Sell	9,614 -21,533	-69%	-$651K	0.31%	72
2023 Q3	$1.03M	Hold	31,147	–	–	1.21%	30
2023 Q2	$1.14M	Sell	31,147 -685	-2%	-$26.7K	1.28%	26
2023 Q1	$1.3M	Hold	31,832	–	–	1.48%	26
2022 Q4	$1.63M	Sell	31,832 -45	-0.1%	-$2.16K	1.98%	18
2022 Q3	$1.4M	Hold	31,877	–	–	1.74%	23
2022 Q2	$1.67M	Hold	31,877	–	–	1.89%	20
2022 Q1	$1.65M	Buy	31,877 +345	+1%	+$17.9K	1.57%	24
2021 Q4	$1.86M	Buy	+31,532	New	+$1.56M	1.61%	25

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wulff, Hansen & Co's PFE Position: Q2 2026 in Review

Wulff, Hansen & Co held its Pfizer (PFE) position steady in Q2 2026 at 11,475 shares worth $276K. The position accounts for 0.21% of the portfolio, ranked #94.

Wulff, Hansen & Co first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.86M in Q4 2021. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Wulff, Hansen & Co held 11,475 shares of Pfizer worth $276K as of Q2 2026.
Wulff, Hansen & Co left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.21% of Wulff, Hansen & Co's portfolio in Q2 2026, its #94 holding.
Wulff, Hansen & Co first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
Wulff, Hansen & Co's Pfizer position peaked at $1.86M in Q4 2021.
2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Wulff, Hansen & Co's 13F filing for Q2 2026, filed 5 Aug 2026.